InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
-11.5%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Wheadon David E., Director. Director active across 5 companies, notably Indivior Pharmaceuticals, Inc.. Aggregated, 12 reports have been logged. History available since 28 May 2021. The latest transaction was filed on 13 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations12 total
10,430 shares0Common StockSEC:0001789507-26-000008
10,430 shares0Common StockSEC:0001789507-26-000008:0
16,000 shares0Common StockSEC:0001437749-24-020098:0
20,089 shares0Common Stock, $0.01 par value per share ("Common Stock")SEC:0000950170-24-066020:0
990 shares@ US$330.00100.0% of flowCommon StockSEC:0001140361-24-013935:0
7,375 shares0Common StockSEC:0001437749-23-021501:0
990 shares0Common StockSEC:0000950170-23-029416:0
15,712 shares0Common Stock, $0.01 par value per share (Common Stock)SEC:0001209191-23-033161:0
7,375 shares0Common StockSEC:0001437749-22-019442:0
10,643 shares0Common Stock, $0.01 par value per share ("Common Stock")SEC:0001822479-22-000038:0
9,336 shares0Common Stock, $0.01 par value per share ("Common Stock")SEC:0001822479-21-000044:0
9,336 shares0Common Stock, $0.01 par value per share ("Common Stock")SEC:0001822479-21-000044
12 of 12 declarations
About Wheadon David E.
David E. Wheadon is a Board Member at Indivior Pharmaceuticals, Inc. and Sotera Health Co. He brings expertise in corporate governance and strategy. His role on the board is essential in guiding the strategic decisions of the companies.
